Quick Takeaways
- TAKEDA PHARMACEUTICAL CO LTD has 7 issuer positions tracked on this page.
- Estimated disclosed ownership value: $119,795,928.
- Recent insider filing activity is available below.
Insider Trading & Ownership of TAKEDA PHARMACEUTICAL CO LTD
- Location
- Tokyo, Japan
- Summary
- The estimated value of insider holdings of TAKEDA PHARMACEUTICAL CO LTD is at least $119,795,928 dollars as of 09 Dec 2025. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $71.54M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $30.42M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Ovid Therapeutics Inc. and owns shares of Ovid Therapeutics Inc. (OVID) stock worth about $11.68M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Theseus Pharmaceuticals, Inc. and owns shares of Theseus Pharmaceuticals, Inc. stock worth about $4.93M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.22M.
- Signature
- /s/ Max Heuer, Authorized Signatory, Takeda Pharmaceutical Company Limited
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow TAKEDA PHARMACEUTICAL CO LTD and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Day One Biopharmaceuticals, Inc. ($71,544,250).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of TAKEDA PHARMACEUTICAL CO LTD
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals, Inc. | 10%+ Owner | $71,544,250 | 07 Dec 2021 | ||
| PHAT | Phathom Pharmaceuticals, Inc. | 10%+ Owner | $30,420,222 | 24 Jan 2024 | ||
| OVID | Ovid Therapeutics Inc. | 10%+ Owner | $11,680,054 | 08 Dec 2025 | ||
| THRX | Theseus Pharmaceuticals, Inc. | 10%+ Owner | $4,927,052 | 12 Oct 2021 | ||
| XLO | Xilio Therapeutics, Inc. | 10%+ Owner | $1,224,350 | 26 Oct 2021 | ||
| HLVX | HilleVax, Inc. | 10%+ Owner | $0 | 17 Sep 2025 | ||
| CALA | Calithera Biosciences, Inc. | Former 10% Owner | 17 Apr 2023 |
Insider Transactions Reported by TAKEDA PHARMACEUTICAL CO LTD:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.